Moreover, IL4I1 can stimulate the expression of AHR target genes TIPARP and CYP1B1 in CD8+ T cells, contributing to the suppression of CD8+ T cell function and potentially aiding tumor progression.169. Here, CD8A is linked to neoplasm.